Gingko biloba, commonly referred to as
gingko or maidenhair
tree, is a member of the Gingkoaceae family. [1] Botanically, gingko is a deciduous
tree growing up to 100m in height. [2] It is a dioecious plant, meaning the
male and female flowers grow on
separate trees. The leaves have a
characteristic fan-like appearance,
bi-lobed, and appear with a
dichotomous venation. The naked seed
of the Gingko tree is a nut which is
edible and was used in the past as
a medicinal agent. However, the leaves of
younger trees are now the part of the
plant that used for medicinal
application.
Extracts of Gingko exhibit a slightly sour
taste.
Gingko is an
ancient tree that has remained
virtually unchanged for
approximately 150 million years. It
can live up to 1000 years and is
considered a living fossil, being the
world's oldest living tree species.
The Chinese are credited with saving
this tree from extinction as they
planted it around holy sights as a
revered specimen.
Gingko was used medicinally
by the Chinese over 5000 years ago, where it was prescribed for some of
the same conditions it is used for
today, including enhancement of
cognitive ability in the aging
population.
There are two main
categories of active constituents,
responsible for the remedial powers of Gingko: Ginkgo flavone glycosides (flavonoid
glycosides), and Terpene lactones (terpenoids). [3,
4]
Extracts of gingko are
standardized to contain 24% Ginkgo
flavone glycosides and 6% terpenoids. The flavone glycosides include
quercetin, kaempferol, isorhamnetin
(including coumaric acid esters of
flavonoids). These important constituents
contribute to the antioxidant
activity and mild platelet
aggregation inhibitory activity of
Gingko.
The terpene lactones
comprise the Ginkgolides and
bilobalide(s) A, B, C, and J. [5]
Terpenoids are associated with
increased circulatory activity to
the brain and other parts of the
body; as well as protective properties for
neurons (nerve cells). Other
constituents found in the leaves of
Gingko trees include; biflavonoids,
sterols, gingkolic acids,
procyanadins, and polysaccharides.
The standardized
Gingko extract is the form used
for clinical application and in
research studies. It is often
considered the most effective and
beneficial form of Gingko, as it contains
significant amounts of the
medicinally active
compounds. Gingko extract was
actually patented in Germany, and is
prepared over a 2 week period where
more than 50 pounds of Gingko leaves
are converted into one pound of
extract. [5] If one was to use preparations that
were not standardized, the volume of
extract needed to be effective would
contain high levels of undesirable
compounds. Furthermore, the sheer
volume of extract required would not
be practical to prescribe.
Medicinal actions
ascribed to Gingko include; [1,
2,
6,
7]
-
PAF (platelet activating factor)
-
antagonist
-
antioxidant
-
anti-atherosclerotic
-
tissue
perfusion enhancer
-
circulatory
stimulant
-
nootropic (means
"acting on the mind")
-
anti-inflammatory
-
anti-thrombotic
A large collection of
evidence exists for the use of
Gingko as a medicinal agent. Gingko is
one of the most intensely researched
herbal medicines, beginning with the
German investigations in the late
1950s and early 1960s. Gingko is
widely known for its use in the
elderly for the treatment of age
related-cognitive decline (ARCD), or
memory impairment in healthy
individuals; as well as cerebrovascular insufficiency.
Gingko extract
for the treatment of cerebrovascular
insufficiency has been extensively
studied. This term refers to a
diminished flow of blood to the
brain, common in the elderly,
resulting in symptoms such as; memory
loss, disorientation, fatigue,
anxiety, dizziness and depression. The pharmacologic action of Gingko
extract equals enhancing circulation to
the brain and inhibiting
platelet aggregation; making it a
prime candidate for treatment of
this such cognitive disorders. Trials have
consistently shown results that
support Gingko's use in
cerebrovascular insufficiency. A
meta-analysis of 11 double-blind, placebo-controlled trials concluded
that Gingko extract provides a
better therapeutic effect than
placebo for the treatment of this
condition. [8]
An important trial
was conducted in the United States
to examine the safety and efficacy
of Gingko extract for
patients with mild to severe
Alzheimer's disease or multi-infarct
dementia. [9] A large randomized double-blind, placebo-controlled clinical trial
(which is the gold standard) lasting
one year investigated the administration
of a 120 milligram daily dose of
standardized (50:1) extract or
placebo. Patients were assessed
using standardized evaluations,
including the Geriatric Evaluation
by Relative's Rating Instrument
(GERRI). The results showed that
patients taking the standardized
gingko extract had significant
improvements over placebo in two out
of three of the evaluation tools. As
well, the standardized gingko
extract produced no significant
difference in adverse effects over
placebo. The authors concluded that
for patients with dementia,
standardized gingko extract is a
safe and effective therapy for
stabilizing and improving cognitive
performance and social function.
Numerous other studies have
exhibited similar findings. [10,
11]
Gingko is also
an efficacious treatment for
intermittent claudication, which is
classified as a peripheral arterial
disease (PAD). Patients generally
experience bouts of severe pain in
their legs due to poor circulation
to the extremities. Randomized
double-blind, placebo-controlled
clinical trials have demonstrated
the benefit of Gingko for patients
suffering from this painful disease. [12-14] A meta-analysis of these trials was
performed, concluding that the use of standardized Gingko extract is
similar to clinical outcomes of
specific drug therapies, namely pentoxifylline. [15] Other clinical trials have
demonstrated improved walking
performance, improvement in rapid
anti-ischemic activity, and reduced
pain severity. [16-17]
Another possible
application for Gingko extract
is for sexual
dysfunction of vascular etiology.
A small,
open study of 30 men showed that
Ginkgo can reduce sexual problems
caused by antidepressants like fluoxetine, bupropion, venlafaxine,
and nefazodone. [18]
The results revealed that
approximately 200 milligrams (mg) of
supplemental Ginkgo
per day had a positive effect on
sexual function in 76% of the men. This effect is likely
caused by Gingko's activity in enhancing blood
flow.
In addition,
Gingko may be beneficial for the
treatment of
early-stage macular degeneration, asthma symptoms,
atherosclerosis, migraines, vertigo,
premenstrual syndrome, cochlear
deafness, and diabetic retinopathy. [19,
20]
As mentioned,
preparations of Gingko should only
be utilized if they are of the 50:1
standardized extract type,
specifically containing 24% flavone
glycosides and 6% terpenoids. All of
the research concerning the efficacy
and safety of Gingko extracts were conducted
using
this potency of standardized extract. Furthermore, this extract eliminates
many other constituents, including bioflavonoids, ginkolic acids, and
sterols, which may cause adverse
effects.
Typical dosages of the
50:1 standardized Gingko
extract exist as 120 mg daily,
administered in
divided doses (equivalent to 27 - 30
mg Gingko flavone glycosides and 10
mg terpenoids per day). Generally,
40 mg tablets and 40 mg/ml liquids
are available. Gingko should be
administered for at least 6 weeks
before being reassessed. This
time frame may, however, vary depending on the condition
being treated. Combination products
on the market include Tanakan, Rkan,
Ginkgobil, Kaveri, and Tebonin. [4]
|
Gingko Biloba Toxicities and
Contraindications |
Caution must be taken
in patients with blood clotting
disorders. Three case reports of
spontaneous bleeding with Ginkgo use
have been reported (both
standardized and non-standardized
preparations). [2]
Cases where there is excessive
bleeding may also be
contraindicated, such as menorrhagia.
Ginkgo may be contraindicated in
anovulatory amenorrhea.
Gingko may
interact with a number of
prescription medications. [21]
Gingko should be avoided in patients
taking anticoagulant or antiplatelet
medications like warfarin, heparin
and aspirin. Other drug interactions
include possible potentiation of MAO
inhibitors and potentiation of
papaverine.
The raw seeds, stems
and leaves contain
4'-O-methylpyroxidine which can
cause vitamin B6 deficiency symptoms
including convulsions. [22,
23] The
stems have been measured to contain
42 mg per gram fresh weight. The
oral toxic dose in guinea pigs was
11 mg/kg. Bilobalide appears to
decrease the toxic affect. Side
effects from the consumption of the
leaf include gastrointestinal
discomfort, headaches and dizziness;
from the fruit/nut includes erythema,
edema, vesicles and severe
gastrointestinal irritation.[4]
No overdose cases have been
documented with use of the
standardized extract.
The following table lists various
products that contain a safe and
reliable source of Gingko Biloba:
|
Manufacturer |
Ingredient |
Amount |
US RDA |
Learn More |
|
NSI |
Ginkgo Biloba Extract |
120mg |
-- |
Click Here
 |
|
Kyolic |
Ginkgo Biloba Leaf Extract 50:1 |
40mg |
-- |
Click Here
 |